Contract notice: Pharmaceutical products Tender, Denmark - 33815680

Procurement Summary

Country : Denmark

Summary : Contract notice: Pharmaceutical products

Deadline : 23 Aug 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 33815680

Document Ref. No. : 274392-2019

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AMGROS I/S
Office Name: Amgros I/S
Address: Dampfærgevej 22
Town: Copenhagen
Postal Code: 2100
Contact Point: Flemming Sonne

Phone: +45 88713000
Fax: +45 88713008
Denmark
Email :udbud@amgros.dk
URL :http://www.amgros.dk

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: Lowest price
CPV code: 33600000, 33600000, 33600000
CPV Description: Pharmaceutical products.

Amgros 2020-1.752.b.

Amgros is a partnership with the five regions as stakeholders. In order to provide the stakeholders` hospital pharmacies with medicinal products, as well as the resale of individual stakeholders to the Faroes and Greenland, Amgros I / S wishes to enter into framework agreements for the medicinal products specified in Section II.2.4. The framework agreements are non-exclusive. Amgros I / S resells laethe funds for the hospital pharmacies for Amgros I / S` purchase price with a supplement. Framework agreements are entered into without the obligation to buy, and the hospital pharmacies in the regions are not obliged to use Amgros` framework agreements.

Main Site: Place of delivery is the address specified by Amgros on the order (hospital pharmacy or associated locations).

The tender number includes the following medicines:

Supply no .: 1,

ATC Code: L03AA02,

Generic name: Filgrastim,

Dispensing form: Injection solution, hat glass,

Strength: 0.3 mg / ml,

Unit value: 0.35 mg,

Quantity in units: 759.

The drugs listed above are offered independently of the drugs under the Other tender numbers

Each tender number is considered to be a separate sub-contract. A supplier will thus be able to choose to bid on one, more or all supply numbers, and assignSeparately occurs for each individual tender number. Reference is made to the terms of the tender, including the submission of tenders under the individual tender numbers.

Under the designation "quantity in units" an estimated consumption of the medicinal products is stated below the tender number, but the actual consumption may differ materially from there. This must be offset by the suppliers. The reason for this is that they are medicines for pattreatment at the public hospitals, where the patient`s needs must be met. For a more detailed description, see point VI.3, clause of the tender specifications 3.6 and the framework agreement clause 2.

The drugs must have marketing authorization valid for Denmark by 2.9.2019 at noon. 12:00. Furthermore, at the time of the deadline for submission of tenders and during the duration of the framework agreement, the supplier must haveve Authorization for the manufacture, import or wholesale sale of medicinal products within the EU / EOS.

Vendors wishing to submit tenders must use the standard form for the Common European Procurement Document (ESPD) to declare the compulsory exclusion grounds in - 135-136 in the Public Procurement Act (Act No. 1564 of 15 December 2015 with amendments). More information about fill-ine and application of the ESPD in the tender process can be found in the guidance prepared by Amgros on this and in the Competition and Consumer Agency`s "Guide to the Common European Procurement Document". The winning supplier (s) whom Amgros intends to award to the Framework Agreement must further have made documentation available to Amgros in respect of the mandatory exclusions before the award- 152 - 153 of the Public Procurement Act. Amgros cannot exclude a supplier covered by one or more of the mandatory grounds for exclusion in - 135-136 of the Public Procurement Act, provided that the supplier can provide sufficient documentation that the supplier is nonetheless reliable, cf. section 138 of the Public Procurement Act. Amgros reserves the right to implement such a "self-cleaning" process, safIf the math is relevant, no information is required. II.2.3 It should be noted that a list of places of delivery is available on Amgros` Supplier and Procurement Portal https://levportal.amgros.dk The overview is updated continuously, provided there are modest changes. II.2.4 notes that Amgros has considered whether the bidding group can be further subdivided. Amgros has sConsidered that this is not the case on the basis of considerations of economies of scale that will not be feasible through a further division and costs and patient safety concerns related to the subsequent contract and drug handling. II.1.5. II.2.6 note that the estimated value in item II.1.5 is the total estimated value for all tendersnumbers (sub-agreements) in the duration of the framework agreement incl. possibility of extension, cf. II.2.7. In point. II.2.6 is the estimated value for each tender number incl. possibility of extension specified, cf. II.2.7.

It is further noted that the estimated value is calculated on the basis of the AIP (list price) of the specific packages that form the basis of the stated "quantity in units" of item. II.2.4and that the actual purchase can therefore differ materially from there, cf. II.2.4, clause of the tender conditions 3.6 and the framework agreement clause 2.

Requests for the tender documents must be made in the tendering system, cf. the provisions of the tender terms and conditions.

Access to tender requires that the company is established as a user of Amgros` procurement system. There may be some handling days associated with med user creation, and it is therefore incumbent on any tenderers to ensure this in good time. Reference is made to information relating to the tendering system, including the user manual. IV.2.4 notes that some parts of the offer may also be in English. Reference is made to the terms of the tender terms. 4.1.

In relation to item. VI.2 notes that electronic billing requiresis.


Internet address (URL): http://www.amgros.dk

Documents

 Tender Notice